Skip to main content
logo
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.270
-0.020 (-0.87%)
Sep 1, 2026, 3:15 PM EDT - Market open

Aytu BioPharma Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
56.666.3865.1873.896.6765.63
Revenue Growth
-14.04%1.84%-11.68%-23.66%47.29%137.52%
Gross Profit
36.6645.8349.0552.2350.2829.2
Operating Income
-6.92.540.57-5.21-38.1-38.24
Net Income
-34.06-13.56-15.84-17.05-108.78-58.29
Earnings Per Share
-3.71-2.16-2.86-5.11-74.01-69.61
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
26.7230.9520.0122.9919.3649.65
Total Debt
22.9422.9416.4218.4518.1924.78
Net Cash (Debt)
3.788.023.594.531.1724.87
Net Cash Growth
-123.38%-20.87%286.86%-95.29%-46.03%
Net Cash Per Share
0.411.280.651.360.8029.70

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
1.68-1.94-1.39-5.13-28.82-25.96
Capital Expenditures
-0.03-0.23-0.33---2.34
Free Cash Flow
1.64-2.17-1.72-5.13-28.82-28.31
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
64.78%69.04%75.26%70.77%52.02%44.49%
Operating Margin
-12.19%3.82%0.87%-7.05%-39.42%-58.26%
Pretax Margin
-59.49%-20.71%-15.92%-9.88%-112.64%-88.42%
Profit Margin
-60.17%-20.43%-24.31%-23.11%-112.53%-88.81%
FCF Margin
2.90%-3.26%-2.63%-6.95%-29.82%-43.13%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-9.03----
PS Ratio
0.430.300.270.120.281.92